VEGF may in part mediate the aggressive breast cancer (BC) phenotype associated with HER2 overexpression[18,19], and constitutively active HER2 has been shown to increase VEGF protein synthesis levels in human BC cells[20]. Here, ERBB2 is linked to breast carcinoma.